RenovoRx (RNXT) Insider Trading & Ownership $1.14 +0.05 (+4.59%) (As of 11:42 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends RenovoRx (NASDAQ:RNXT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.10%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$22,431.26Number OfInsiders Selling(Last 3 Years)0 Get RNXT Insider Trade Alerts Want to know when executives and insiders are buying or selling RenovoRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RNXT Insider Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! RenovoRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/3/2023Angela NelmsCOOBuy1,100$1.05$1,155.00 6/7/2022Ramtin AgahInsiderBuy5,182$1.93$10,001.26 5/19/2022Shaun BagaiCEOBuy5,500$2.05$11,275.00 (Data available from 1/1/2013 forward) RNXT Insider Trading Activity - Frequently Asked Questions Who is on RenovoRx's Insider Roster? The list of insiders at RenovoRx includes Angela Nelms, Ramtin Agah, and Shaun Bagai. Learn more on insiders at RNXT. What percentage of RenovoRx stock is owned by insiders? 7.10% of RenovoRx stock is owned by insiders. Learn more on RNXT's insider holdings. Which RenovoRx insiders have been buying company stock? The following insider purchased RNXT shares in the last 24 months: Angela Nelms ($1,155.00). How much insider buying is happening at RenovoRx? Insiders have purchased a total of 1,100 RNXT shares in the last 24 months for a total of $1,155.00 bought. RenovoRx Key ExecutivesDr. Ramtin Agah M.D. (Age 58)Founder, Chairman of Board & Chief Medical Officer Compensation: $332.89kMr. Shaun R. Bagai (Age 47)CEO, Secretary & Director Compensation: $589.38kMr. Ronald B. Kocak CPA (Age 67)CGMA, VP, Controller & Principal Accounting Officer Ms. Leesa Gentry (Age 54)Chief Clinical Officer More Insider Trading Tools from MarketBeat Related Companies Inhibikase Therapeutics Insider Transactions Cyclo Therapeutics Insider Transactions CalciMedica Insider Transactions FibroGen Insider Transactions Monopar Therapeutics Insider Transactions Rockwell Medical Insider Transactions Anixa Biosciences Insider Transactions Immunic Insider Transactions Genelux Insider Transactions X4 Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:RNXT) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
